Ioannis Sapountzis
Global Head BD&L @ Boehringer Ingelheim
Ioannis Sapountzis is a grant investor at Boehringer Ingelheim focused on Life Science and Therapeutics. Ioannis Sapountzis
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Ioannis Sapountzis invests in
Stages Ioannis Sapountzis invests in
Countries Ioannis Sapountzis invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Proxygen
|
Proxygen is reshaping the druggable space. Their company harnesses technology and know-how to exploit this potential, thereby redefining the borders of the druggable target space. They developed rational discovery assays that, for the first time, enabled the identification and development of novel glue degraders at scale, putting them at theforefront of charting this unexplored chemical space. | Grant / Jul 31, 2020 |
About Boehringer Ingelheim
Boehringer Ingelheim is a research-driven group of companies dedicated to researching, developing, manufacturing, and marketing pharmaceuticals that improve health and quality of life. Our businesses comprise Prescription Medicine, Animal Health, and Biopharmaceuticals.
Boehringer Ingelheim Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Anjan Chatterjee
Corporate Vice President
|
|||
Christian Eckermann
SVP, Head of Biopharma Austria
|
|||
|
Ioannis Sapountzis
Global Head BD&L
|
|||
Jan Cassen Kraus
Head of Supply Chain Management
|
|||
Klaus-Peter Kammerer
Global Clinical Program Leader
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ioannis Sapountzis invest in?
Ioannis Sapountzis invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ioannis Sapountzis?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ioannis Sapountzis last invest?
The most recent investment recorded for Ioannis Sapountzis closed in Jul 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
